CRChristiane Rolim-De-Moura

Christiane Rolim-De-Moura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christiane Rolim-De-Moura has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the TD-8000 ® rebound tonometer: Accuracy and agreement with Perkins ® tonometer in children under 8 years

    by Ana Flávia Lacerda Belfort, Hevila Rolim, Janaína Miranda Guimarães, Arthur Moreira de Freitas, Christiane Rolim-De-Moura, Francisco das Chagas Lima Silva

    Objective: To evaluate the feasibility, accuracy, and correlation of intraocular pressure (IOP) measurements obtained with the TD-8000 ® rebound tonometer compared with Perkins ® applanation tonometry in children with glaucoma or suspected glaucoma. Methods: This prospective diagnostic accuracy study included 78 eyes of 44 children under 8 years. IOP was measured using the TD-8000 ® during outpatient visits and under general anesthesia. Perkins ® tonometry was performed under general anesthesia. Diagnostic performance was calculated using a 21 mmHg cutoff. Agreement was evaluated using correlation and Bland–Altman methods. Results: Rebound tonometry was feasible in 89% of awake children. Under general anesthesia, TD-8000 ® overestimated IOP compared with Perkins ® , with a mean difference of 9.06 mmHg (SE = 0.62; p < 0.001). Accuracy was 87.5%, sensitivity 22.2%, specificity 98.2%, negative predictive value 88.5% and positive predictive value 66.7%. Outpatient rebound IOP measurements correlated weakly with applanation under general anesthesia (R = 0.32; p = 0.04). Conclusions: The TD-8000 ® is a feasible but less accurate tool for IOP measurement in young children. Weak correlation between outpatient rebound tonometry and applanation under general anesthesia limits its reliability, although high specificity may offer clinical value in high-prevalence settings.

  • Open Access

    Preliminary results of lateral interaction and radial deformity hyperacuity in children with glaucoma

    by Christiane Rolim-De-Moura, Carolina P. B. Gracitelli, Otavio Correa Pinho, Marcelo Fernandes da Costa

    This study aimed to assess lateral spatial interaction (LSI) and radial deformity hyperacuity (RDH) in children with glaucoma and compare them with a normal control group. A cross-sectional study was conducted on both eyes of 16 participants (8 children with glaucoma and 10 age-matched control). LSI and RDH were collected in the same day. Children with glaucoma exhibited a lower interaction effect (F = 4.48; p = 0.035) compared to age-matched control children. Differences were observed in measurement conditions with and without flanks, except for frequency 0.8 cpd. Additionally, radial deformation hyperacuity thresholds were significantly higher for all stimulus conditions in children with glaucoma compared to controls: 5-point distortion (0.125 cpg F = 8.27, p = 0.007; 0.5 cpg F = 14.72, p < 0.001), 10-point distortion (0.125 cpg F = 8.15, p = 0.007; 0.5 cpg F = 8.15, p = 0.026), and 15-point distortion (0.125 cpg F = 5.92, p = 0.020; 0.5 cpg F = 9.98, p = 0.003). Children with glaucoma demonstrated a reduced spatial contrast interaction and higher radial deformation hyperacuity thresholds, indicating decreased information input to higher visual areas.

  • Open Access

    360° trabeculotomy ab externo with double access for the treatment of congenital glaucoma

    by Flávia S. Villas Boas, Ana Catharina Pinho Costa, Christiane Rolim-De-Moura, Carolina P. B. Gracitelli

    Purpose: This study aims to describe the technique, feasibility, efficacy, and safety of 360° trabeculotomy ab externo with double access for the treatment of congenital glaucoma. Methods: This paper provides a detailed description of the 360° trabeculotomy ab externo with double access used to treat pediatric glaucoma. The postoperative outcomes of six eyes from six patients who underwent this procedure for primary and secondary congenital glaucoma are also reported. Results: Six eyes from six patients were included in this study. The median age of the patients at the time of surgery was 1.25 yr (range: 0.27-5.41 yr). The mean preoperative intraocular pressure was 25 ± 5.87 mmHg (range: 18-35 mmHg). At baseline, the mean number of hypotensive eye drop medications used was 2 ± 0.63. Postoperatively, the mean intraocular pressure decreased to 10 ± 2.20 mmHg (range: 9-14 mmHg), and none of the patients required hypotensive eye drops. The most common postoperative complication was hyphema, observed in one case on the first postoperative day; however, it resolved within 7 days. Conclusions: The 360° trabeculotomy ab externo with double access is a valuable addition to the surgical options for pediatric glaucoma. This technique facilitates a complete 360° ab externo opening of the trabecular meshwork while enhancing surgical safety.

  • Laser trabeculoplasty for open-angle glaucoma and ocular hypertension

    by Christiane R Rolim-De-Moura, Augusto Paranhos, Mohamed Loutfi, David Burton, Richard Wormald, Jennifer R Evans

    Background Open‐angle glaucoma (OAG) is an important cause of blindness worldwide. Laser trabeculoplasty, a treatment modality, still does not have a clear position in the treatment sequence. Objectives To assess the effects of laser trabeculoplasty for treating OAG and ocular hypertension (OHT) when compared to medication, glaucoma surgery or no intervention. We also wished to compare the effectiveness of different laser trabeculoplasty technologies for treating OAG and OHT. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2021, Issue 10); Ovid MEDLINE; Ovid Embase; the ISRCTN registry; LILACS, ClinicalTrials.gov and the WHO ICTRP. The date of the search was 28 October 2021. We also contacted researchers in the field. Selection criteria We included randomised controlled trials (RCTs) comparing laser trabeculoplasty with no intervention, with medical treatment, or with surgery in people with OAG or OHT. We also included trials comparing different types of laser trabeculoplasty technologies. Data collection and analysis We used standard methods expected by Cochrane. Two authors screened search results and extracted data independently. We considered the following outcomes at 24 months: failure to control intraocular pressure (IOP), failure to stabilise visual field progression, failure to stabilise optic neuropathy progression, adverse effects, quality of life, and costs. We graded the 'certainty' of the evidence using GRADE. Main results We included 40 studies (5613 eyes of 4028 people) in this review. The majority of the studies were conducted in Europe and in the USA. Most of the studies were at risk of performance and/or detection bias as they were unmasked. None of the studies were judged as having low risk of bias for all domains. We did not identify any studies of laser trabeculoplasty alone versus no intervention. Laser trabeculoplasty versus medication Fourteen studies compared laser trabeculoplasty with medication in either people with primary OAG (7 studies) or primary or secondary OAG (7 studies); five of the 14 studies also included participants with OHT. Six studies used argon laser trabeculoplasty and eight studies used selective laser trabeculoplasty. There was considerable clinical and methodological diversity in these studies leading to statistical heterogeneity in results for the primary outcome "failure to control IOP" at 24 months. Risk ratios (RRs) ranged from 0.43 in favour of laser trabeculoplasty to 1.87 in favour of medication (5 studies, I2 = 89%). Studies of argon laser compared with medication were more likely to show a beneficial effect compared with studies of selective laser (test for interaction P = 0.0001) but the argon laser studies were older and the medication comparator group in those studies may have been less effective. We considered this to be low‐certainty evidence because the trials were at risk of bias (they were not masked) and there was unexplained heterogeneity. There was evidence from two studies (624 eyes) that argon laser treatment was associated with less failure to stabilise visual field progression compared with medication (7% versus 11%, RR 0.70, 95% CI 0.42 to 1.16) at 24 months and one further large recent study of selective laser also reported a reduced risk of failure at 48 months (17% versus 26%) RR 0.65, 95% CI 0.52 to 0.81, 1178 eyes). We judged this outcome as moderate‐certainty evidence, downgrading for risk of bias. There was only very low‐certainty evidence on optic neuropathy progression. Adverse effects were more commonly seen in the laser trabeculoplasty group including peripheral anterior synechiae (PAS) associated with argon laser (32% versus 26%, RR 11.74, 95% CI 5.94 to 23.22; 624 eyes; 2 RCTs; low‐certainty evidence); 5% of participants treated with laser in three studies of selective laser group had early IOP spikes (moderate‐certainty evidence). One UK‐based study provided moderate‐certainty evidence that laser trabeculoplasty was more cost‐effective. Laser trabeculoplasty versus trabeculectomy Three studies compared laser trabeculoplasty with trabeculectomy. All three studies enrolled participants with OAG (primary or secondary) and used argon laser. People receiving laser trabeculoplasty may have a higher risk of uncontrolled IOP at 24 months compared with people receiving trabeculectomy (16% versus 8%, RR 2.12, 95% CI 1.44 to 3.11; 901 eyes; 2 RCTs). We judged this to be low‐certainty evidence because of risk of bias (trials were not masked) and there was inconsistency between the two trials (I2 = 68%). There was limited evidence on visual field progression suggesting a higher risk of failure with laser trabeculoplasty. There was no information on optic neuropathy progression, quality of life or costs. PAS formation and IOP spikes were not reported but in one study trabeculectomy was associated with an increased risk of cataract (RR 1.78, 95% CI 1.46 to 2.16) (very low‐certainty evidence). Authors' conclusions Laser trabeculoplasty may work better than topical medication in slowing down the progression of open‐angle glaucoma (rate of visual field loss) and may be similar to modern eye drops in controlling eye pressure at a lower cost. It is not associated with serious unwanted effects, particularly for the newer types of trabeculoplasty, such as selective laser trabeculoplasty.


  • Open Access

    Evaluation of childhood cataract characteristics at a tertiary referral center

    by Ana Paula Silverio Rodrigues, Célia Regina Nakanami, Christiane Regina Rolim de Moura Souza, Nilva Simerem Bueno Moraes, Andréa Araújo Zin, Denise de Freitas

    Purpose: To examine the epidemiological characteristics of children undergoing cataract surgery at a referral center in Sao Paulo State, Brazil, as well as the facts surrounding treatment delays. Methods: In this transversal observational study, 240 operated eyes from 178 children undergoing cataract surgery were reviewed. The following aspects were analyzed: epidemiological and clinical characteristics, parental observations, red reflex test, operated eye, and age at cataract diagnosis and surgery. Results: The mean ages at the first visit and cataract surgery were 48.9 months (SD=50.0 months) and 64.5 months (SD= 55.4 months), respectively. The most critical sign adverted by parents was leukocoria. The red reflex test was performed on two-thirds of the children, with abnormal results in 28.0%. A family history of cataracts was evident in 30 (20,9%) children (n=144). Previous ocular surgery was found in 37 (16,6%) of the eyes (n=223), anterior segment disorders in 20 (9,0%) eyes (n=221), strabismus in 21 (9,5%) of the eyes (n=220), and nystagmus in 38 (24,4%) of the children (n=156). Conclusions: One of the causes for the delay in admission may have been the failure to complete the red reflex. In terms of etiology, heredity was the most crucial component. The presence of strabismus and nystagmus in many of these children points to late diagnosis. The most significant impediments to adequate cataract treatment in children were the lack of referral programs and children’s specialized ophthalmologic centers, in addition to the restricted number of support professionals trained in the field and pediatric ophthalmology specialists.


  • Psychosocial indicators of primary congenital glaucoma and filtering surgeries impacts on children and family’s quality of life

    by Andrea Oliveira da Silva, Christiane Rolim-De-Moura, Nara Lúcia Poli Botelho, Carolina Pb Gracitelli, Nívea Nunes Ferraz

    To identify psychosocial indicators and evaluate the filtering surgeries impacts on quality of life (QOL) of children with primary congenital glaucoma (PCG) and their family. Parents of children with bilateral PCG who underwent filtering surgery were included. Data were collected through: (a) psychological inquiry to determine psychosocial indicators; (b) Children’s Visual Function Questionnaire (CVFQ). The associations between the CVFQ scores and visual acuity, intraocular pressure, optic disk cupping, horizontal corneal diameter, axial length, number of surgeries, and hypotensive eye drops were investigated. The statistical significance level was considered as p ⩽ 0.05. The mean age of the nine mothers interviewed and their children (six boys and three girls) was 29 ± 5 years and 35 ± 18 months, respectively. The psychosocial indicators determined were: emotional impact of the diagnosis, disease knowledge, mother and family’s feelings on facing the surgical treatment, surgical result comprehension, treatment adherence, child's emotional and behavioral reactions, social support, and future expectations. In CVFQ analysis, QOL score was strongly associated with visual acuity (r = −0.79; p = 0.01). Besides the treatment score was correlated to intraocular pressure (r = −0.68; p < 0.05), optic disk cupping (r = −0.85; p = 0.03), and corneal diameter (r = −0.69; p = 0.02). Correlations were not found for number of surgeries and eye drops. This study confirmed the PCG surgical treatment impact on QOL and determined psychosocial indicators which may favor the suitable actions in psychological treatment and follow-up of the children and families.


  • Open Access

    Baerveldt implant versus trabeculectomy as the first filtering surgery for uncontrolled primary congenital glaucoma: a randomized clinical trial

    by Christiane Rolim-De-Moura, Bruno L. B. Esporcatte, Camila F. Netto, Augusto Paranhos Jr.

    Purpose: Our initial goal was to compare the efficacy and safety of a glaucoma drainage device and trabeculectomy for children with primary congenital glaucoma after angular surgery failure. However, we discontinued the study due to the rate of complications and wrote this report to describe the results obtained with the two techniques in this particular group. Methods: This was a parallel, non-masked, controlled trial that included patients aged 0-13 years who had undergone previous trabeculotomy or goniotomy and presented inadequately controlled glaucoma with an intraocular pressure ≥21 mmHg on maximum tolerated medical therapy. We randomized the patients to undergo either placement of a 250-mm2 Baerveldt glaucoma implant or mitomycin-augmented trabeculectomy. The main outcome measure was intraocular pressure control. We calculated complete success (without hypotensive ocular medication) and qualified success (with medication) rates. We defined failure as uncontrolled intraocular pressure, presence of serious complications, abnormal increase in ocular dimensions, or confirmed visual acuity decrease. Results: We studied 13 eyes of 13 children (five in the glaucoma drainage device group; eight in the trabeculectomy group). Both surgical procedures produced a significant intraocular pressure reduction 12 months after intervention from the baseline (tube group, 22.8 ± 5.9 mmHg to 12.20 ± 4.14 mmHg, p=0.0113; trabeculectomy group, 23.7 ± 7.3 mmHg to 15.6 ± 5.9 mmHg, p=0.0297). None of the patients in the tube group and 37.5% of those in the trabeculectomy group achieved complete success in intraocular pressure control after 12 months of follow-up (p=0.928, Chi-square test). Two patients (40%) had serious complications at the time of tube aperture (implant extrusion, retinal detachment). Conclusions: Both the tube and trabeculectomy groups presented similar intraocular pressure controls, but complete success was more frequent in the trabeculectomy group. Non-valved glaucoma drainage devices caused potentially blinding complications during tube opening. Because of the small sample size, we could not draw conclusions as to the safety data of the studied technique.


  • Laser trabeculoplasty for open angle glaucoma

    by Christiane R Rolim de Moura, Augusto Paranhos Jr, Richard Wormald

    Open angle glaucoma (OAG) is an important cause of blindness worldwide. Laser trabeculoplasty, a treatment modality, still does not have a clear position in the treatment sequence. The objective of this review was to study the effects of laser trabeculoplasty for OAG. We identified trials from CENTRAL in The Cochrane Library, MEDLINE, EMBASE, LILACS and manual searching. We also contacted researchers in the field. We included randomised controlled trials comparing laser trabeculoplasty with no intervention, with medical treatment, or with surgery. We also included trials comparing different technical modalities of laser trabeculoplasty. Two authors independently assessed trial quality and extracted the data. We contacted trial investigators for missing information. This review included 19 trials involving 2137 participants. Only five trials fulfilled the criteria of good methodological quality. One trial compared laser trabeculoplasty with topical beta-blocker to no intervention in early glaucoma. The risk of glaucoma progression was higher in the control group at six years of follow up (risk ratio (RR) 0.71 95% confidence interval (CI) 0.53 to 0.95). No difference in health-related quality of life was observed between the two groups. Three trials compared laser trabeculoplasty to medication (regimens used before the 1990s) in people with newly diagnosed OAG. The risk of uncontrolled intraocular pressure (IOP) was higher in the medication group compared to the trabeculoplasty group at six months and two years of follow up. Three trials compared laser trabeculoplasty with trabeculectomy. The risk of uncontrolled IOP was significantly higher in the trabeculoplasty group at six months but significant heterogeneity was observed at two years. Diode and selective laser are compared to argon laser trabeculoplasty in three trials and there is some evidence showing a comparable effect in controlling IOP at six months and one year of follow up. Evidence suggests that, in people with newly diagnosed OAG, the risk of uncontrolled IOP is higher in people treated with medication used before the 1990s when compared to laser trabeculoplasty at two years follow up. Trabeculoplasty is less effective than trabeculectomy in controlling IOP at six months and two years follow up. Different laser technology and protocol modalities were compared to the traditional laser trabeculoplasty and more evidence is necessary to determine if they are equivalent or not. There is no evidence to determine the effectiveness of laser trabeculoplasty compared to contemporary medication (prostaglandin analogues, topical anhydrase inhibitors and alpha2-agonists) and also with contemporary surgical techniques. Also there should be further investigation in to the effectiveness of laser trabeculoplasty in specific racial groups, specific diagnostic groups, such as pseudoexfoliation and pigmentary glaucoma and different stages of OAG. More research is also required determining cost-effectiveness of laser trabeculoplasty in the management of glaucoma.